X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/aveo-oncology-announces-completion-of-enrollment-in-pivotal-phase-3-tinivo-2-study-of-fotivda-tivozanib-in-combination-with-opdivo-nivolumab-in-advanced-renal-cell-carcinoma-301864465.html
https://endpts.com/korean-buyer-jumps-into-ma-game-with-566m-bid-for-aveo-oncology/
https://investor.aveooncology.com/news-releases/news-release-details/lg-chem-acquire-aveo-oncology-1500-share-cash
https://www.globenewswire.com/news-release/2022/10/12/2533371/0/en/U-S-Patent-Trademark-Office-Allows-AVEO-Oncology-s-Patent-Application-Covering-Use-of-FOTIVDA-for-the-Treatment-of-Refractory-Advanced-Renal-Cell-Carcinoma.html
https://www.globenewswire.com/news-release/2022/09/21/2520171/0/en/AVEO-Oncology-Announces-Participation-at-the-Cantor-Fitzgerald-Oncology-HemOnc-Conference.html
https://www.globenewswire.com/news-release/2022/08/31/2507634/0/en/AVEO-Oncology-Announces-Participation-at-Investor-Conferences-in-September.html
https://www.globenewswire.com/news-release/2022/08/04/2492814/0/en/AVEO-Oncology-Reports-Second-Quarter-2022-Financial-Results.html
https://www.globenewswire.com/news-release/2022/07/28/2488321/0/en/AVEO-Oncology-to-Announce-Second-Quarter-2022-Financial-Results-on-August-4-2022.html
https://www.globenewswire.com/news-release/2022/06/22/2467067/0/en/AVEO-Oncology-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Eli-Lilly-and-Company-for-ERBITUX-cetuximab-in-North-America-to-Evaluate-Ficlatuzumab-and-Cetuximab-i.html
https://www.globenewswire.com/news-release/2022/06/06/2456662/0/en/AVEO-Oncology-Presents-Three-Posters-for-Tivozanib-at-the-2022-ASCO-Annual-Meeting.html
Market Place
Share 
